Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srividya Swaminathan

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|November 11, 2014
Follicular lymphoma: too many reminders for a memory B cellSrividya Swaminathan, Markus Müschen
Oncotarget|July 22, 2015
Infectious origins of childhood leukemiaSrividya Swaminathan, Markus Müschen
ACS Pharmacology & Translational Science|July 20, 2023
Dichloro Ru(II)-<i>p</i>-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case StudySrividya Swaminathan, Ramasamy Karvembu
Haematologica|March 21, 2024
Type I interferons: leukemia's old foe in the limelight againAnil Kumar, Srividya Swaminathan
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2004
Bacterial artificial chromosome engineeringSrividya Swaminathan, Shyam K Sharan
Vitamins and Hormones|August 14, 2025
B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptorSrividya Swaminathan, Ameae M Walker
Trends in Immunology|December 17, 2013
BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpointSrividya Swaminathan, Cihangir Duy, Markus Müschen
Chemmedchem|October 7, 2024
From Concept to Cure: The Road Ahead for Ruthenium-Based Anticancer DrugsSrividya Swaminathan, Jebiti Haribabu, Ramasamy Karvembu
Exploratory Research and Hypothesis in Medicine|March 2, 2026
Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and ChallengesAnil Kumar, Adeleh Taghi Khani, Srividya Swaminathan
Immunological Reviews|December 17, 2014
Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemiaMaike Buchner, Srividya Swaminathan, Zhengshan Chen, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|November 11, 2014
Follicular lymphoma: too many reminders for a memory B cellSrividya Swaminathan, Markus Müschen
Oncotarget|July 22, 2015
Infectious origins of childhood leukemiaSrividya Swaminathan, Markus Müschen
ACS Pharmacology & Translational Science|July 20, 2023
Dichloro Ru(II)-<i>p</i>-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case StudySrividya Swaminathan, Ramasamy Karvembu
Haematologica|March 21, 2024
Type I interferons: leukemia's old foe in the limelight againAnil Kumar, Srividya Swaminathan
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2004
Bacterial artificial chromosome engineeringSrividya Swaminathan, Shyam K Sharan
Vitamins and Hormones|August 14, 2025
B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptorSrividya Swaminathan, Ameae M Walker
Trends in Immunology|December 17, 2013
BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpointSrividya Swaminathan, Cihangir Duy, Markus Müschen
Chemmedchem|October 7, 2024
From Concept to Cure: The Road Ahead for Ruthenium-Based Anticancer DrugsSrividya Swaminathan, Jebiti Haribabu, Ramasamy Karvembu
Exploratory Research and Hypothesis in Medicine|March 2, 2026
Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and ChallengesAnil Kumar, Adeleh Taghi Khani, Srividya Swaminathan
Immunological Reviews|December 17, 2014
Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemiaMaike Buchner, Srividya Swaminathan, Zhengshan Chen, et al.
Pageof 6